In women who developed hirsutism at the third month of treatment, LH and 17-OH PG levels were found to be statistically significantly lower and DHEAS levels were found to be statistically significantly higher than at the beginning of the treatment (p < 0.05). The gene discussed is SULT2A1; the disease is Hirsutism.